Cost Considerations and Insurance Coverage Both Zepbound and Wegovy are premium medications with significant monthly costs: Zepbound: Approximately $1,000-1,350 per month without insurance Wegovy: Approximately $1,300-1,400 per month without insurance Insurance Coverage: Coverage varies significantly by insurance plan
The Canadian regulatory environment for obesity medications has historically prioritized caution over speed
This is the strongest piece of evidence in Dihexa's favor, and it is important to frame it accurately: it is a small rodent study in a disease model, not a human trial, and not a measure of cognitive enhancement in healthy people
2.3 Overview of ferroptosis-associated changes in OA tissues Recent studies have established a strong association between ferroptosis and the pathological features of OA, including cartilage degeneration, subchondral bone remodeling, and synovial inflammation